Robert Aronowitz, a physician and historian at the University of Pennsylvania, has been elected to membership in the Institute of Medicine, one of the nation's highest honors in the health-care field.
Blue light can both set the mood and set in motion important biological responses.
By Madeleine Stone @themadstone
Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania
In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Michael A. Nutter
Penn Center for Innovation Launch Celebration
Nov. 17, 2014
The Penn Center for Innovation, a new initiative that will provide the infrastructure, leadership and resources needed to transfer promising Penn inventions, know-how and related assets into the marketplace for the public good, will be formally launched at an event on Monday, November 17.
Gutmann, Nutter, Bonnell and Swartley will discuss how PCI will accelerate the translation of Penn discoveries and ideas into commercial products, businesses, and services, as well as the role the University plays in the local, national and global entrepreneurial ecosystem.
Top Penn researchers and members of the business and venture capital community will have the opportunity to meet at a reception to follow.
Attendance is free and open to the public, but email registration is mandatory.